No Data
No Data
Ipsen S.A. (IPSEY) Q4 2024 Earnings Call Transcript Summary
Ipsen Targets 5%+ Sales Growth and 30%+ Margin for 2025 Amid Strong Pipeline and Launches
Here's the Major Earnings Before the Open Tomorrow
Eton Pharmaceuticals Enters Asset Purchase Agreement To Acquire Increlex (Mecasermin Injection) From Ipsen; No Terms Disclosed
Gilead Wins FDA Nod for Liver Disease Drug
Gilead Exits J&J Royalty Deal for Liver Drug Ahead of Potential FDA Nod
Unlock the Full List
SanjBot : nothing like a few gallstones to make you feel alive.